(2024) 31:20392051.e2036
Mecanismo de accin El GLP-1 ejerce sus efectos biolgicos mediante la activacin del receptor del GLP-1 (GLP-1R), un receptor acoplado a protena G (GPCR) ampliamente distribuido en diversos tejidos, incluyendo el pncreas endocrino, el sistema nervioso central, el tracto gastrointestinal, el sistema cardiovascular y el rin (2)
"With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need." According to Eli Lilly, adults in the Phase 3 trials all lost weight with orforglipron and on the highest dose of 36 mg of orforglipron, the trial participants lost about 27 pounds over the course of 72 weeks or about 12% of their body weight, which is meaningful but not quite as high as some injectables
It emerged from a body of protein-engineering work in the late 1980s and early 1990s much of it from the Australian laboratories associated with Francis, Ballard, and Wallace aimed at producing IGF analogs with reduced IGFBP affinity but preserved receptor activity, in order to study the relative contributions of binding-protein interaction versus receptor binding to biological potency